BioSpace14d
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded ...
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
Why your co-pay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
pharmaphorum2d
FDA rethinking block on compounding of Lilly's obesity drug
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...
NBC Chicago14d
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Amgen said its experimental weight loss injection helped patients lose up to 20% of their weight on average after a year, with no plateau ... That's unlike Eli Lilly's obesity drug, Zepbound ...
NBC 10 Philadelphia21d
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial
The treatment demonstrates the diversity of Eli Lilly's drug pipeline beyond its top-selling weight loss and diabetes treatments ... There are currently no approved treatments to lower Lp ...
Insider Monkey17d
Jim Cramer on Eli Lilly and Company (LLY): ‘It’s Valuable’
No one else can do that. They aren’t rich enough. The GLP-1s, they represent value because it’s not just about diabetes and weight loss, they’re lifesavers… GLP-1’s not some simple hack ...